Principal Investigator
Khema Sharma
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20250476
Clinical Trial Summary
A Phase 3, Randomized, Double-Blinded, Double-Dummy Study
Evaluating the Efficacy and Safety of Empasiprubart Versus
Intravenous Immunoglobulin in Adults With Multifocal Motor
Neuropathy
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Other